Back

Midkine Attenuates Aβ Fibril Assembly and Amyloid Plaque Formation

Zaman, M.; Yang, S.; Huang, Y.; Yarbro, J. M.; Hao, Y.; Wang, Z.; Liu, D.; Harper, K. E.; Soliman, H.; Hemphill, A.; Harvey, S.; Pruett-Miller, S. M.; Stewart, V.; Tanwar, A. S.; Kalathur, R.; grace, c. r.; Turk, M.; Chittori, S.; Jiao, Y.; Wu, Z.; High, A. A.; Wang, X.; Serrano, G. E.; Beach, T.; YU, G.; Yang, Y.; Chen, P.-C.; Peng, J.

2025-03-20 biochemistry
10.1101/2025.03.20.644383 bioRxiv
Show abstract

Proteomic profiling of Alzheimers disease (AD) brains has identified numerous understudied proteins, including midkine (MDK), that are highly upregulated and correlated with A{beta} since the early disease stage, but their roles in disease progression are not fully understood. Here we present that MDK attenuates A{beta} assembly and influences amyloid formation in the 5xFAD amyloidosis mouse model. MDK protein mitigates fibril formation of both A{beta}40 and A{beta}42 peptides in Thioflavin T fluorescence assay, circular dichroism, negative stain electron microscopy, and NMR analysis. Knockout of Mdk gene in 5xFAD increases amyloid formation and microglial activation. Further comprehensive mass spectrometry-based profiling of whole proteome and detergent-insoluble proteome in these mouse models indicates significant accumulation of A{beta} and A{beta}-correlated proteins, along with microglial components. Thus, our structural and mouse model studies reveal a protective role of MDK in counteracting amyloid pathology in Alzheimers disease.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.